Demir Bingol

Demir Bingol currently serves as the VP of Divestitures & Out Licensing at Bayer since August 2022. Prior to this role, Bingol was President of mPathix Health from March 2021 to August 2022 and held the position of Head of BD&L at STADA Corp USA between December 2019 and March 2021. Bingol has extensive experience in business development and marketing, having served as VP and Head of Business Development & Licensing for The Americas at Grünenthal from July 2013 to December 2019, along with a tenure as Interim CEO at GRUNENTHAL USA, INC. from January 2018 to June 2019. Previous positions include Vice President of Commercial Marketing at WellDoc, Inc., Sr. Director of the Oral Pain Solutions Group at Endo Pharmaceuticals, Sr. Marketing Director at Adolor, and Sr. Marketing Director at aaiPharma, with a foundational role as Brand Director at AstraZeneca. Bingol earned an MBA in Marketing from Old Dominion University and a BSBA in Marketing from Christopher Newport University.